Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2991189956;89957;89958 chr2:178553169;178553168;178553167chr2:179417896;179417895;179417894
N2AB2827085033;85034;85035 chr2:178553169;178553168;178553167chr2:179417896;179417895;179417894
N2A2734382252;82253;82254 chr2:178553169;178553168;178553167chr2:179417896;179417895;179417894
N2B2084662761;62762;62763 chr2:178553169;178553168;178553167chr2:179417896;179417895;179417894
Novex-12097163136;63137;63138 chr2:178553169;178553168;178553167chr2:179417896;179417895;179417894
Novex-22103863337;63338;63339 chr2:178553169;178553168;178553167chr2:179417896;179417895;179417894
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATT
  • RefSeq wild type template codon: TAA
  • Domain: Ig-147
  • Domain position: 70
  • Structural Position: 155
  • Q(SASA): 0.2292
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/S rs1261129308 None 0.175 N 0.515 0.151 0.587387877561 gnomAD-3.1.2 6.57E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
I/S rs1261129308 None 0.175 N 0.515 0.151 0.587387877561 gnomAD-4.0.0 6.56901E-06 None None None None N None 0 0 None 0 0 None 0 0 1.46977E-05 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.3214 likely_benign 0.2595 benign -2.106 Highly Destabilizing 0.055 N 0.445 neutral None None None None N
I/C 0.5281 ambiguous 0.4841 ambiguous -1.604 Destabilizing 0.667 D 0.52 neutral None None None None N
I/D 0.6262 likely_pathogenic 0.5299 ambiguous -1.581 Destabilizing 0.667 D 0.589 neutral None None None None N
I/E 0.5036 ambiguous 0.4211 ambiguous -1.406 Destabilizing 0.364 N 0.571 neutral None None None None N
I/F 0.1387 likely_benign 0.1301 benign -1.244 Destabilizing 0.096 N 0.448 neutral N 0.502268837 None None N
I/G 0.627 likely_pathogenic 0.5252 ambiguous -2.595 Highly Destabilizing 0.364 N 0.542 neutral None None None None N
I/H 0.3101 likely_benign 0.2705 benign -1.925 Destabilizing 0.667 D 0.576 neutral None None None None N
I/K 0.3229 likely_benign 0.2867 benign -1.324 Destabilizing 0.364 N 0.549 neutral None None None None N
I/L 0.1144 likely_benign 0.1009 benign -0.736 Destabilizing None N 0.199 neutral N 0.439622868 None None N
I/M 0.1075 likely_benign 0.0979 benign -0.848 Destabilizing 0.427 N 0.507 neutral N 0.483683077 None None N
I/N 0.1993 likely_benign 0.1588 benign -1.476 Destabilizing 0.822 D 0.574 neutral N 0.45440032 None None N
I/P 0.9556 likely_pathogenic 0.9316 pathogenic -1.169 Destabilizing 0.859 D 0.59 neutral None None None None N
I/Q 0.3304 likely_benign 0.28 benign -1.402 Destabilizing 0.859 D 0.571 neutral None None None None N
I/R 0.2422 likely_benign 0.2066 benign -1.084 Destabilizing 0.667 D 0.575 neutral None None None None N
I/S 0.1965 likely_benign 0.155 benign -2.294 Highly Destabilizing 0.175 N 0.515 neutral N 0.440276229 None None N
I/T 0.1347 likely_benign 0.1053 benign -1.973 Destabilizing 0.081 N 0.478 neutral N 0.355809406 None None N
I/V 0.0738 likely_benign 0.0693 benign -1.169 Destabilizing None N 0.203 neutral N 0.397429529 None None N
I/W 0.695 likely_pathogenic 0.6685 pathogenic -1.457 Destabilizing 0.958 D 0.595 neutral None None None None N
I/Y 0.3657 ambiguous 0.3237 benign -1.168 Destabilizing 0.004 N 0.305 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.